The START Center for Cancer Research Adds Carolina Urologic Research Center to Network
The START Center for Cancer Research announced on March 18 the expansion of its network with the acquisition of Carolina Urologic Research Center (CURC) located in Myrtle Beach, South Carolina. Financial terms of the deal were not disclosed. CURC is a clinical research clinic specializing in genitourinary (GU) oncology. Under the direction of Dr. Neal Shore, CURC conducts phase I – IV drug, biotechnology and device trials focusing on urological diseases. CURC has conducted nearly 500 clinical trials, making it the top urologic oncology site worldwide by both volume and quality. CURC is a separate and independent research arm of Grand Strand Urology, a division of Atlantic Urology Clinics.... Read More »
Clario Announces Second Acquisition of March 2025
Clario announced on March 17 that it has acquired Canadian company NeuroRx. This marks Clario’s second acquisition of the month. Based in Montreal, Quebec, NeuroRx is an imaging contract research organization (CRO) that works with the pharmaceutical industry to bring new drugs to market. NeuroRx offers a full set of services including protocol development, qualification and supervision of MRI facilities, as well as collection and analysis of standardized image data. Clario, formerly ERT and Bioclinica, is a CRO specializing in clinical services and customizable medical devices to biopharmaceutical and healthcare organizations. The company is based in Philadelphia, Pennsylvania. Earlier in... Read More »
Walgreens Has Finally Been Sold
After months of rumors and speculation, Walgreens has finally announced it is being sold for nearly $10 billion in cash, or approximately $17 billion if we include debt. Although many already know Walgreens as a retail giant, it has been making a significant push into the healthcare market for the past years, but that plan has backfired. According to its annual report for fiscal year 2024, the company reported an operating loss of $14.1 billion (yes, billion), largely due to the loss in value of VillageMD, its primary care subsidiary and the principal vehicle for its healthcare initiative. Walgreens’ healthcare strategy was on display in the M&A market; in addition to the company’s... Read More »
Montecito Medical Buys Three MOBs in Georgia
Montecito Medical Real Estate announced that it has acquired three medical office buildings in Georgia for an undisclosed price. The sale includes three medical outpatient buildings (MOBs) in the Atlanta MSA occupied by Aylo Health. The properties— in Ball Ground, Woodstock and Dawsonville, Georgia respectively—comprise a total of 52,726 square feet. Aylo Health is a dominant, multi-specialty physician group with 61 physicians across 14 locations in the Atlanta area. The group focuses on primary care and pediatrics, with imaging and sleep medicine. Montecito Medical specializes in healthcare-related real estate acquisitions and funding. Since 2006, it has completed transactions involving... Read More »
